SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCSRT.L Regulatory News (CSRT)

  • There is currently no data for CSRT

Form 8.5 (EPT/RI)

22 Jan 2020 11:20

RNS Number : 6017A
GoldmanSachs International
22 January 2020
 

 

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

(GS) GOLDMAN SACHS INTERNATIONAL

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

CONSORT MEDICAL PLC

(c) Name of the party to the offer with which exempt principal trader is connected:

RECIPHARM HOLDINGS LIMITED (A WHOLLY-OWNED SUBSIDIARY OF RECIPHARM AB)

(d) Date dealing undertaken:

21 January 2020

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

N/A

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

10p ordinary

Purchases

51,511

10.1974 GBP

10.1000 GBP

10p ordinary

Sales

1,610

10.2000 GBP

10.1750 GBP

 

 

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

10p ordinary

CFD

Opening a short position

7,703

10.1000 GBP

10p ordinary

CFD

Opening a short position

8,908

10.1000 GBP

10p ordinary

CFD

Opening a short position

16,389

10.1000 GBP

10p ordinary

CFD

Increasing a short position

16,901

10.1000 GBP

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising / exercised against

Number of securities

Exercise price per unit

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

NONE

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

NONE

 

 

 

Date of disclosure:

22 January 2020

Contact name:

Kashif Rafiq and Papa Lette

Telephone number:

+44(20) 7051 0547 / +44(20) 7774 7442

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
FERBBGDBCBDDGGD
Date   Source Headline
10th Mar 20102:26 pmRNSRule 8.3- (Consort Medical)
10th Mar 20102:16 pmRNSRule 8.3- Consort Medical PLC
8th Mar 201010:23 amRNSRule 8.3- (Consort Medical Plc)
4th Mar 201012:07 pmRNSDIRECTORSHIP
3rd Mar 201010:54 amRNSRule 8.3- Consort Medical Plc
2nd Mar 20101:07 pmRNSRule 8.3- Consort Medical Plc
2nd Mar 201012:55 pmRNSRule 8.3-Consort Medical Plc - Amendment
2nd Mar 201010:27 amRNSRule 8.3- Consort Medical plc
2nd Mar 20109:27 amRNSStatement re Possible Offer
1st Mar 201012:09 pmRNSRule 8.3- Consort Medical Plc
1st Mar 20107:00 amRNSRule 2.10 Announcement
26th Feb 20102:51 pmRNSPossible Offer
26th Feb 201011:16 amRNSStatement re Possible Offer
18th Feb 20101:21 pmRNSNotification of Major Interest in Shares
19th Jan 20102:13 pmRNSNotification of Transactions of Directors
15th Dec 20091:42 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
11th Dec 20093:57 pmRNSDetails of Share Dealings
10th Dec 20097:00 amRNSINTERIM RESULTS
2nd Dec 200912:33 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
19th Nov 20096:22 pmRNSOffer Update
5th Nov 200912:38 pmRNSOffer Update
5th Nov 20098:59 amRNSRule 8.1- The Medical House Plc
4th Nov 20098:48 amRNSRule 8.1- The Medical House Plc
3rd Nov 200910:00 amRNSRule 8.1- The Medical House Plc
29th Oct 20094:23 pmRNSOffer Update
28th Oct 20092:07 pmRNSDetails of Share Dealings
15th Oct 20094:36 pmRNSOffer Update
13th Oct 200912:51 pmRNSDirectorate Change
5th Oct 20094:54 pmRNSDirector/PDMR Shareholding
28th Sep 200910:30 amRNSRule 8.1- The Medical House Plc
24th Sep 20097:00 amRNSOffer for The Medical House PLC
21st Sep 200912:32 pmRNSBlock Listing 6 Monthly Return
18th Sep 20097:00 amRNSInterim Management Statement
17th Sep 20094:40 pmRNSSecond Price Monitoring Extn
17th Sep 20094:35 pmRNSPrice Monitoring Extension
16th Sep 20094:20 pmRNSAnnual General Meeting
21st Aug 200912:16 pmRNSDetails of Share Dealings
14th Aug 200911:04 amRNSNotification of Major Interests in Shares
27th Jul 200911:46 amRNSNOTIFICATION OF MAJOR INTEREST IN SHARES
21st Jul 20093:56 pmRNSBlock Listing Six Monthly Return
3rd Jul 20094:35 pmRNSPrice Monitoring Extension
24th Jun 20097:00 amRNSPreliminary Results
18th Jun 20094:49 pmRNSBLOCK LISTING SIX MONTHLY RETURN
3rd Jun 20094:40 pmRNSSecond Price Monitoring Extn
3rd Jun 20094:35 pmRNSPrice Monitoring Extension
3rd Jun 20099:30 amRNSNotice of Results
2nd Jun 20095:12 pmRNSBlock Listing Six Monthly Return
27th May 20094:35 pmRNSPrice Monitoring Extension
11th May 20092:19 pmRNSHolding(s) in Company
6th May 20091:14 pmRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.